Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details Narrative)

v3.19.1
Income Taxes (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income tax benefit $ (13,582) $ (6,880)
Federal operating losses 70,468  
State operating losses $ 30,907  
Percentage of future taxable income 21.00% 34.00%
Deferred tax assets net operating loss carry forward [1],[2] $ 16,849 $ 15,003
Deferred research tax credit carryforwards 203 203
Unrecognized income tax benefits   $ 13
U.S. corporate income tax rate   35.00%
Reduction of U.S. corporate income tax rate   21.00%
Deferred tax liabilities indefinite-lived intangibles 6,587  
Additional income tax benefits 293  
Deferred income tax expense benefit (13,582) $ (6,880)
Deferred tax assets valuation allowance 19,779 17,841
Federal [Member]    
Federal operating losses $ 8,829  
Net operating loss carry forward, expiration 2026  
Research and development tax credit carryforwards $ 1,820  
Tax credit carryforwards expire term The federal research and development tax credit carryforwards begin to expire in 2028  
Deferred research tax credit carryforwards $ 820  
State [Member]    
Net operating loss carry forward, expiration 2028  
Federal And State [Member]    
Net operating loss carry forward, expiration 2023  
California [Member]    
Research and development tax credit carryforwards $ 257  
Deferred tax assets net operating loss carry forward 1,190 $ 1,115
Deferred research tax credit carryforwards $ 257  
[1] California net operating loss carryforwards of $1,190,000 and $1,115,000,
[2] Georgia net operating loss carry forwards of $543,000 and $941,000,